Announcements Trials
Browse Landscape

Phase

Phase 2 3

Status

Completed 5Active not recruiting 4Unknown 3Recruiting 2Withdrawn 1Terminated 1

Sponsor Class

OTHER 3OTHER_GOV 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 2Gastrointestinal 2Breast 1

Conditions

Carcinoma, Non-Small-Cell Lung 2Stomach Neoplasms 1Gastrointestinal Neoplasms 1Breast Neoplasms 1Adenocarcinoma 1

Interventions

Cisplatin 352Oxaliplatin 262Capecitabine 258Radiotherapy 240Gemcitabine 223Docetaxel 223Carboplatin 223Cyclophosphamide 219Drug Therapy 218Paclitaxel 205apatinib 201Bevacizumab 195camrelizumab 190Fluorouracil 187sintilimab 133Blood Specimen Collection 125Irinotecan 124Dexamethasone 123Etoposide 119Radiosurgery 118toripalimab 117Surgical Procedures, Operative 115pembrolizumab 110Pemetrexed 108anlotinib 105S 1 (combination) 105Surveys and Questionnaires 101Leucovorin 101Nivolumab 98tislelizumab 96

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × OTHER × ipatasertib × Clear all
NCT04467801 2023-11-07

Ipat-Lung

University of Kansas Medical Center

Phase 2 Unknown
60 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04591431 2023-10-03

ROME

Fondazione per la Medicina Personalizzata

Phase 2 Unknown
400 enrolled
BreastGastrointestinalThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Gastrointestinal Neoplasms

NCT04739202 2021-03-29

IMMUNOGAST

Hospices Civils de Lyon

Phase 2 Unknown
60 enrolled
Gastrointestinal

Adenocarcinoma, Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡